Andrea Galli

Dr. Andrea Galli

Otorhinolaryngology, IRCCS Ospedale San Raffaele, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oral Oncology
Verified
Journal Article
Closed access
DLDavide Lombardi
Davide Lombardi
MTMichele Tomasoni
Michele Tomasoni
APAlberto Paderno
Alberto Paderno
DMDavide Mattavelli
Davide Mattavelli
MFMarco Ferrari
Marco Ferrari
PNPiero Nicolai
Piero Nicolai

11 May 2016 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
LGLeone Giordano
Leone Giordano
DSDavide Di Santo
Davide Di Santo
AOAntonio Occhini
Antonio Occhini
Andrea GalliAndrea Galli
Andrea Galli
GBGiulia Bertino
Giulia Bertino
MBMario Bussi
Mario Bussi

1 June 2019 in Acta Otorhinolaryngologica Italica
Verified
Journal Article
Open access
PDF file
Andrea GalliAndrea Galli
Andrea Galli
LGLeone Giordano
Leone Giordano
MBM. Biafora
M. Biafora
MTM. Tulli
M. Tulli
DSD. Di Santo
D. Di Santo
MBM. Bussi
M. Bussi
Total laryngectomy is the standard of care for advanced laryngeal/hypopharyngeal cancer. Effective voice rehabilitation is mandatory and tracheo-oesophageal speech (TES) has progressively gained approval. In 2011, we evaluated quality of life (QoL) and satisfaction after TES rehabilitation, demonstrating its efficacy in highly motivated subjects. The aim of the present study was to investigate whether those results are maintained over time within the same selected cohort. 15 of 24 patients were left with a minimum 12 year-follow up after voice prosthesis (VP) implantation. Short Form 36-Item Health Survey (SF-36) for QoL assessment and a study-specific structured questionnaire for evaluation of TES-related satisfaction were employed. The 9/24 patients who dropped out from the follow-up were excluded from the original count and the former results were recalculated. A control group of subjects with minor ENT diseases was used for SF-36 analysis. Many SF-36 items (RP, BP, SF, RE) significantly improved over time, approaching the results of the control group. VP duration also increased (6.3 ± 3.1 against 3.0 ± 1.8 months). TES-related satisfaction items did not change in a statistically significant way. Three patients (20.0%) would not have chosen the same kind of voice restoration: these subjects are those more distant from our institution (230 km and 462 km, respectively, against a mean distance of 15.4 ± 13.8 km for other patients). With the present work, we highlight how the striking results of TES can not only be maintained over time (i.e. TES-related satisfaction), but also substantially improve (i.e. QoL). An integrated, widespread network of centres for VP management is needed to optimise patient follow-up and allow studies on larger series.

13 November 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
MTMichele Tulli
Michele Tulli
MRMassimo Re
Massimo Re
SBStefano Bondi
Stefano Bondi
LFLuigi Ferrante
Luigi Ferrante
MDMarianxhela Dajko
Marianxhela Dajko
MBMario Bussi
Mario Bussi

13 June 2020 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
Andrea GalliAndrea Galli
Andrea Galli
MCMichele Colombo
Michele Colombo
GCGiulia Carrara
Giulia Carrara
FLFrancesca Lira Luce
Francesca Lira Luce
PPPier Luigi Paesano
Pier Luigi Paesano
MBMario Bussi
Mario Bussi

17 October 2017 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
MTMichele Tulli
Michele Tulli
SBStefano Bondi
Stefano Bondi
CSChanel Elisha Smart
Chanel Elisha Smart
LGLeone Giordano
Leone Giordano
Matteo TrimarchiMatteo Trimarchi
Matteo Trimarchi
MBMario Bussi
Mario Bussi